Skip to main content

Table 2 IMP-characteristics of Advagraf™

From: EnGraft: a multicentre, open-label, randomised, two-arm, superiority study protocol to assess bioavailability and practicability of Envarsus® versus Advagraf™ in liver transplant recipients

IMP name

Advagraf™

Active ingredient

Tacrolimus monohydrate

Pharmaceutical form

Prolonged-release hard capsule

Presentation

Gelatin capsule with light yellow/white/orange/greyish-red capsule cap on an orange capsule body containing white powder in respectively 0.5 mg/1 mg/3 mg/5 mg dosage strengths

Administration

Once daily, oral formulation provided in 0.5 mg, 1.0 mg, 3.0 mg and 5.0 mg dosage strengths